Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 57 (3) , 261-267
- https://doi.org/10.1016/j.biopsych.2004.10.032
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in miceEuropean Journal of Neuroscience, 2004
- ‘One‐trial sensitization’ to the anxiolytic‐like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus‐mazeEuropean Journal of Neuroscience, 2003
- The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyEuropean Journal of Neuroscience, 2002
- A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxietyPublished by Elsevier ,1998
- Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the ratNeuroReport, 1997
- Differential Effects of Chronic Treatment with Either Dopamine D1 or D2 Receptor Agonists on the Acute Neuroendocrine Actions of the Highly Potent Synthetic Cannabinoid HU-210 in Male RatsNeuroendocrinology, 1995
- Some critical determinants of the behaviour of rats in the elevated plus-mazeBehavioural Processes, 1993
- Chronic mild stress-induced anhedonia: A realistic animal model of depressionNeuroscience & Biobehavioral Reviews, 1992
- Animal models for the study of anti-anxiety agents: A reviewNeuroscience & Biobehavioral Reviews, 1985
- Depression: a new animal model sensitive to antidepressant treatmentsNature, 1977